Genomic Data Analysis Service Market Report – Research, Industry Analysis Reports and Market Demands

Global Genomic Data Analysis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Genomic Data Analysis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Genomic Data Analysis Service by Company Revenue
- 3.2.2 Top 3 Genomic Data Analysis Service Players Market Share in 2025
- 3.2.3 Top 6 Genomic Data Analysis Service Players Market Share in 2025
3.3 Genomic Data Analysis Service Market: Overall Company Footprint Analysis
- 3.3.1 Genomic Data Analysis Service Market: Region Footprint
- 3.3.2 Genomic Data Analysis Service Market: Company Product Type Footprint
- 3.3.3 Genomic Data Analysis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Genomic Data Analysis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Genomic Data Analysis Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Genomic Data Analysis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Genomic Data Analysis Service Market Forecast by Application (2027-2032)

6 North America

6.1 North America Genomic Data Analysis Service Consumption Value by Type (2021-2032)
6.2 North America Genomic Data Analysis Service Market Size by Application (2021-2032)
6.3 North America Genomic Data Analysis Service Market Size by Country
- 6.3.1 North America Genomic Data Analysis Service Consumption Value by Country (2021-2032)
- 6.3.2 United States Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 6.3.3 Canada Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Genomic Data Analysis Service Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Genomic Data Analysis Service Consumption Value by Type (2021-2032)
7.2 Europe Genomic Data Analysis Service Consumption Value by Application (2021-2032)
7.3 Europe Genomic Data Analysis Service Market Size by Country
- 7.3.1 Europe Genomic Data Analysis Service Consumption Value by Country (2021-2032)
- 7.3.2 Germany Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 7.3.3 France Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 7.3.5 Russia Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 7.3.6 Italy Genomic Data Analysis Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Genomic Data Analysis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Genomic Data Analysis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Genomic Data Analysis Service Market Size by Region
- 8.3.1 Asia-Pacific Genomic Data Analysis Service Consumption Value by Region (2021-2032)
- 8.3.2 China Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 8.3.3 Japan Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 8.3.5 India Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 8.3.7 Australia Genomic Data Analysis Service Market Size and Forecast (2021-2032)

9 South America

9.1 South America Genomic Data Analysis Service Consumption Value by Type (2021-2032)
9.2 South America Genomic Data Analysis Service Consumption Value by Application (2021-2032)
9.3 South America Genomic Data Analysis Service Market Size by Country
- 9.3.1 South America Genomic Data Analysis Service Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Genomic Data Analysis Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Genomic Data Analysis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Genomic Data Analysis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Genomic Data Analysis Service Market Size by Country
- 10.3.1 Middle East & Africa Genomic Data Analysis Service Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Genomic Data Analysis Service Market Size and Forecast (2021-2032)
- 10.3.4 UAE Genomic Data Analysis Service Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Genomic Data Analysis Service Market Drivers
11.2 Genomic Data Analysis Service Market Restraints
11.3 Genomic Data Analysis Service Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Genomic Data Analysis Service Industry Chain
12.2 Genomic Data Analysis Service Upstream Analysis
12.3 Genomic Data Analysis Service Midstream Analysis
12.4 Genomic Data Analysis Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Genomic Data Analysis Service market size was valued at US$ 5847 million in 2025 and is forecast to a readjusted size of US$ 9964 million by 2032 with a CAGR of 8.0% during review period.
Genomic Data Analysis Service refers to a professional service that processes, analyzes, interprets, and delivers insights from genomic and multi-omics data, most commonly generated by next-generation sequencing (NGS). The service covers the full analytical lifecycle—from raw data handling to biological or clinical interpretation—using validated bioinformatics pipelines, domain knowledge, and compliant data infrastructure.
Gross Margin Level
The gross margin of genomic data analysis services primarily depends on the proportion of "software subscriptions" and "human interpretation/project delivery." Platform-based services (SaaS/IVD software/knowledge base subscriptions) typically have higher gross margins: for example, SOPHiA GENETICS disclosed an adjusted gross margin of approximately 72.8% in 2024, reflecting the high-margin structure brought about by software-based and large-scale delivery. Ecosystem leaders like Illumina, with a combination of "consumables + services/software," also disclosed a gross margin of approximately 65.4% in 2024, indicating that "analytical capabilities" are often tied to high-margin, continuous consumables/services. In contrast, the gross margin of integrated service providers leaning towards "sequencing/experiment + analysis delivery" is lowered by experimental costs, capacity utilization, and project-based manpower. For example, Azenta disclosed a gross margin of approximately 45.5% in FY2025, which is closer to a structure of "multi-omics services + operational delivery." Therefore, from an industry-wide perspective, the mainstream gross profit margin for genomic data analysis services typically falls between 50% and 70%. The higher the proportion of software subscriptions and the more standardized/automated the process, the closer the gross profit margin is to the upper limit; while delivery models with deep customization, strong human interpretation, and strong integration with wet laboratory experiments are closer to the lower-middle range.
Industry Drivers
The fundamental driver of industry growth is the transformation of genomics from a "research tool" to "infrastructure for clinical and pharmaceutical research." On the one hand, the penetration of NGS and the continuous expansion of data volume have turned analysis from an "optional step" into a "bottleneck for project success or failure." On the other hand, the investment of pharmaceutical and biotechnology companies in target discovery, patient stratification, and companion diagnostics has propelled this type of demand into one of the important end-users. Simultaneously, the delivery model is rapidly migrating towards "cloud workflows + reproducible governance": for example, AWS HealthOmics emphasizes managed storage, workflow execution, and analysis capabilities for omics data, reducing setup and compliance costs; Google Cloud Life Sciences also emphasizes using containerized workflows to process and annotate omics/biomedical data at scale, meeting the elastic computing power requirements of large-scale cohorts and multi-center collaborations. With the addition of AI-assisted interpretation, knowledge base integration, and clinical report standardization (such as QIAGEN strengthening its clinical genomics software portfolio through acquisitions), the industry is shifting from "selling tools" to "selling auditable and scalable clinical/pharmaceutical research productivity," thereby supporting a long-term CAGR of mid-to-high double digits.
This report is a detailed and comprehensive analysis for global Genomic Data Analysis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Genomic Data Analysis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Genomic Data Analysis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Genomic Data Analysis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Genomic Data Analysis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genomic Data Analysis Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genomic Data Analysis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, QIAGEN Digital Insights, BGI Genomics, Eurofins Genomics, Charles River Laboratories, CellCarta, CD Genomics, Fios Genomics, Basepair, Golden Helix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Genomic Data Analysis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cloud-Based SaaS Services
On-Premises Deployment Services
Market segment by Delivery Model
Project-Based Outsourcing
Platform Subscription
Managed Analytics
Others
Market segment by Service Target Perspective
Dedicated Services for Medical Institutions
Pharmaceutical R&D Services
Others
Market segment by Application
Healthcare
Biomedicine
Scientific Research and Education
Agricultural Breeding
Others
Market segment by players, this report covers
Illumina
QIAGEN Digital Insights
BGI Genomics
Eurofins Genomics
Charles River Laboratories
CellCarta
CD Genomics
Fios Genomics
Basepair
Golden Helix
DNAnexus
Seven Bridges(Velsera)
SOPHiA GENETICS
Fabric Genomics
Congenica
Novogene
GENEWIZ
Macrogen
AWS HealthOmics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genomic Data Analysis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genomic Data Analysis Service, with revenue, gross margin, and global market share of Genomic Data Analysis Service from 2021 to 2026.
Chapter 3, the Genomic Data Analysis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Genomic Data Analysis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genomic Data Analysis Service.
Chapter 13, to describe Genomic Data Analysis Service research findings and conclusion.

Buy now